Another Women Comes Forward To Accuse Joe Biden Of

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
221
Another Women Comes Forward To Accuse Joe Biden Of Inappropriate Touching

A Connecticut woman has come forward and accused then-Vice President Joe Biden of inappropriately touching her in 2009 at a political fundraising event.

The Hartford Courant reports that Amy Lappos came forward with the allegation after she heard about former Nevada Democrat state Sen. Lucy Flores’ allegations against Biden last week. The Courant reports:

Lappos, 43, who is now a freelance worker with nonprofit agencies, said she felt extremely uncomfortable when Biden approached her at the 2009 fundraiser for U.S. Rep. Jim Himes, D-4th, where she was volunteering. At the time, Lappos was a congressional aide to Himes, who she said was not in the room when the incident took place.

“It wasn’t sexual, but he did grab me by the head,” Lappos told The Courant. “He put his hand around my neck and pulled me in to rub noses with me. When he was pulling me in, I thought he was going to kiss me on the mouth.”

“I never filed a complaint, to be honest, because he was the vice president. I was a nobody,” Lappos continued. “There’s absolutely a line of decency. There’s a line of respect. Crossing that line is not grandfatherly. It’s not cultural. It’s not affection. It’s sexism or misogyny.”

Lappos made the allegation in a Facebook post using the pseudonym Alice Paul. Lappos wrote:

Biden did something similar to me at a fundraiser in Greenwich when I was a Congressional Aide. I’m really disappointed to see this post ask “thoughts” as if the grossness of men invading women’s boundaries to sniff and touch is is debatable. And shame on some of the women here excusing this as boys being boys or it’s not as bad as Trump. I can speak from experience when I say it’s an incredibly uncomfortable situation and not at all acceptable. We need to hold our men to the same standards we hold all men.

The incident reportedly happened on October 5, 2009, inside the home of a housing developer who was hosting the fundraising event.

“If Biden truly supports women and gender equality he would step aside and support one of the many talented and qualified women running,” Lappos added.

The newest allegation against Biden comes after Flores accused Biden last week of sexual harassment, saying that she “had never experienced anything so blatantly inappropriate and unnerving before.”

“Just before the speeches, we were ushered to the side of the stage where we were lined up by order of introduction,” Flores wrote. “As I was taking deep breaths and preparing myself to make my case to the crowd, I felt two hands on my shoulders. I froze. ‘Why is the vice-president of the United States touching me?'”

“I felt him get closer to me from behind. He leaned further in and inhaled my hair. I was mortified,” Flores continued. “He proceeded to plant a big slow kiss on the back of my head. My brain couldn’t process what was happening. I was embarrassed. I was shocked. I was confused. … I wanted nothing more than to get Biden away from me.”

https://rightwingfolks.com/breaking-another-w...-touching/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigel Pharmaceuticals Updates on Financials and Future Plans

Updated Category News Views 130

Rigel Pharmaceuticals' Business Update and 2025 Outlook Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a notable biotechnology company, recently provided a compelling business update, highlighting its financial performance and strategic ambitions for 2025. The report shared preliminary insights into the fourth quarter of 2024, showcasing substantial revenue streams from its...

Continue Reading
Grant Cardone Explores Future of Investments in Bitcoin and Real Estate

Updated Category News Views 409

Understanding Investment Shifts in Today's Economy Grant Cardone, a prominent real estate investor and entrepreneur known for his work with Cardone Capital, is keeping a keen eye on the fluctuations within the investment landscape. With approximately $7 trillion currently held in money markets, he questions where this substantial amount of cash will be allocated as...

Continue Reading
BlueNord ASA Secures Major Funding Through Hybrid Bond Issuance

Updated Category News Views 175

BlueNord ASA Successfully Places Hybrid Bond Issue BlueNord ASA (OSE: BNOR) has achieved a significant milestone in its financial strategy with the successful placement of a new subordinated callable hybrid bond issue worth USD 300 million. This bond matures in 2085, marking a robust step forward for the company. The first call on the hybrid bond is at 100% of nominal...

Continue Reading
Aehr Test Systems (NASDAQ: AEHR) Sees Growth in 2026 Amid Fluctuations

Updated Category News Views 133

Strong Start to 2026 for Aehr Test Systems For shares of Aehr Test Systems, the year 2026 has kicked off in a remarkable way. As of the latest market close, the stock has risen by 44%, showcasing significant investor enthusiasm. This surge follows a recent earnings release that, while presenting mixed signals, ultimately contributed to a 16% jump in the stock price the...

Continue Reading
Carlton Precious Enhances Community Relations and Expansion Plans

Updated Category News Views 151

Carlton Precious Inc. Strengthens Community Engagement TORONTO — Carlton Precious Inc. (TSX-V: CPI | OTCQB: NBRFF), a notable player in precious and base metals exploration, is excited to share significant developments regarding its Esquilache Silver project. The Company has successfully finalized an agreement with the local community of San Antonio de Esquilache, which...

Continue Reading